An Atlanta-based biotech company last week said it successfully concluded the first-ever clinical trial testing of a microarray injection-free vaccine on children as young as 9 months old.

Micron Biomedical tested microneedle-based delivery of the measles-rubella (MR) vaccine on children

The post Trial of Gates-Funded Vaccine Patch for Infants ‘Successful,’ Company Says appeared first on Global Research.

Leave A Comment